Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of Molecular Characterisation of Early Operable Primary Breast Cancer in Pakistani Population

NCT06830590 is registered in ClinicalTrials.gov with Liaquat University of Medical & Health Sciences as lead sponsor.

NCT NCT06830590
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06830590 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of Molecular Characterisation of Early Operable Primary Breast Cancer in Pakistani Population
Lead sponsor
Liaquat University of Medical & Health Sciences
Phase
Observational
Overall status
Recruiting
Start date
February 1, 2016
Completion date
December 31, 2025
Enrollment
300 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, molecular pathway deregulation, treatment